| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.0051 | 1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |